We co-build technology companies,with you.
A blend of founder-to-founder thought partnership and direct portfolio building, guiding emergent technology assets from R&D to fundraising and market launch.
Our Model
Portfolio Co-Building for Life Sciences
We co-build technology companies from the ground up, working with founders to translate breakthrough discoveries into viable commercial enterprises.
We enable founder-controlled company formation while providing hands-on support for strategy, regulatory pathways, pilot studies, and commercialization.
- Discovery
- Translation
- Development
- Commercialization
- For academics & research institutionsResearch Translation
- For inventors & TTOsIntellectual Property
- For early-stage startupsRegulatory Navigation
- For founders & spinoutsCapital & Fundraising
- For foundersResearch Strategy & Partnerships
Our Philosophy
Value Creation Through Embedded Partnership
We build beside you, transforming scientific breakthroughs into fundable, founder-controlled companies through operational value-add at every stage.
Hands-On Partnership
Embedded support for founders and research teams, providing strategic guidance and operational resources.
Execution Focus
Rigorous due diligence, market analysis, and disciplined capital deployment that maximize success.
Strategic Growth
Building fundable companies with clear pathways to value realization and sustainable positioning.
Research Strategy
Research Planned Around the Company It Has to Build
We help founders decide which studies stand between their company and its next commercial milestone, and connect them with the partner labs and contract research organizations suited to the work, so the data a young company needs gets generated without it first having to build a lab of its own.
Commercial Research Strategy
The questions a company has to answer for its next milestone, and the studies, order and timeline that answer them for partners and investors.
Partner Labs and CROs
Partner labs, shared facilities and contract research organizations selected for the method, the materials and the stage, with vendor relationships and timelines managed against the plan.
Data That Carries the Company Forward
Results packaged for the next decision: a licensing discussion, a partnership or a fundraise.
Specializing in regenerative medicine, gene therapy, oncology, and rare diseases with embedded support for founders and research teams.
Get Started
Ready to Transform Your Science into a Company?
We partner with founders and research teams committed to bringing breakthrough science to market.